Hybrids of Iron-Filled Multiwall Carbon Nanotubes and Anticancer Agents as Potential Magnetic Drug Delivery Systems: In Vitro Studies Against Human Melanoma, Colon Carcinoma, and Colon Adenocarcinoma

Journal of Nanomaterials - United States
doi 10.1155/2017/1262309
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

Nanofibers and Applications as Colon Specific Drug Delivery System: Review

Journal of Literature Pharmacy Sciences
2018English

Formulation, in Vitro Drug Release and in Vivo Human X-Ray Investigation of Polysaccharide Based Drug Delivery Systems for Targeting 5-Fluorouracil to the Colon

Brazilian Journal of Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2013English

Copper(II) Complexes as Potential Anticancer and Nonsteroidal Anti-Inflammatory Agents: In Vitro and in Vivo Studies

Scientific Reports
Multidisciplinary
2019English

Hyperthermia Suppresses Post - In Vitro Proliferation and Tumor Growth in Murine Malignant Melanoma and Colon Carcinoma

Anticancer Research
MedicineCancer ResearchOncology
2019English

Recent Advancements in Uracil and 5-Fluorouracil Hybrids as Potential Anticancer Agents: A Review

Journal of Applied Pharmaceutical Science
MedicineToxicologyPharmaceuticsPharmacology
2020English

A Promising Approach to Provide Appropriate Colon Target Drug Delivery Systems of Vancomycin HCL: Pharmaceutical and Microbiological Studies

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2014English

Giant Magnetic Coercivity in Fe3C-Filled Carbon Nanotubes

RSC Advances
ChemistryChemical Engineering
2018English

Binase Immobilized on Halloysite Nanotubes Exerts Enhanced Cytotoxicity Toward Human Colon Adenocarcinoma Cells

Frontiers in Pharmacology
Pharmacology
2017English

Pharmacokinetic Evaluation of Guar Gum-Based Colon-Targeted Drug Delivery Systems of Tinidazole in Healthy Human Volunteers

Drug Delivery
MedicinePharmaceutical Science
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy